Launch week offerEnds in00h00m00s

annual Promonthly Pro

Alessia Cafaro

Health Researcher

Istituto Giannina Gaslini

Italy

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Italy

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (14)

Federica Pigliasco

Istituto Giannina Gaslini

ITALY

View details

Maurizio Miano

IRCCS Istituto Giannina Gaslini

ITALY

View details

Domenico Mavilio

Full professor

University of Milan

ITALY

View details

Arinna Bertoni

Istituto Giannina Gaslini

ITALY

View details

Carlo Castellani

Head of Cystic Fibrosis Center

Istituto Giannina Gaslini

ITALY

View details

Maria Valeria Corrias

Istituto Giannina Gaslini

ITALY

View details

Giacomo Brisca

MD, PhD

Istituto Giannina Gaslini

ITALY

View details

carolina saffioti

Istituto Giannina Gaslini

ITALY

View details

Francesca Mattioli

Associate professor

University of Genoa

ITALY

View details

Andrea Santangelo

University of Pisa

ITALY

View details

Diego Gilioli

Columbia University Irving Medical Center

UNITED STATES

View details

Silvia Della Bella

University of Milan

ITALY

View details

Antonello Di Paolo

Director

University of Pisa

ITALY

View details

Genny Del Zotto

Researcher

Istituto Giannina Gaslini

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Alessia Cafaro

Research Interests

Make your next move.

Explore related searches

Articles (20)

Uncommon causal variants of the ADA2 gene in patients with reduced enzyme activity and nonconfirmatory genetic testing

Therapeutic Drug Monitoring of Antifungal Agents: Toward Harmonization of Therapeutic Ranges

Precision management of cenobamate in drug-resistant epilepsy: integrating pharmacogenetics, therapeutic drug monitoring, and real-world clinical strategies

High-dose continuous infusion of piperacillin/tazobactam via elastomeric pump in a pediatric patient with Kartagener syndrome: pharmacokinetic target attainment and clinical outcome

“Standard” Is More Than Enough: Therapeutic Drug Monitoring Confirms Early Target Attainment of Teicoplanin Regimens in Pediatric Patients

The ‘double hit’ on dalbavancin pharmacokinetics: hypertriglyceridaemia and augmented renal clearance in a child with glycogen storage disease type Ib

Indicazioni per l'armonizzazione degli intervalli terapeutici per i farmaci antifungini

NET Proteomic Profiling Reveals New Pathways Potentially Implicated in Dendritic Cell-Mediated Inflammation in DADA2 Patients

A Novel LC-MS/MS Method for the Measurement of Elexacaftor, Tezacaftor and Ivacaftor in Plasma, Dried Plasma Spot (DPS) and Whole Blood in Volumetric Absorptive Microsampling (VAMS) Devices

Etiology and Oral Antibiotic Susceptibility Patterns of the First Urinary Tract Infection Episode in Infants Under 6 Months of Age: A 17-Year, Retrospective, Single-Center Study in Italy

A Real-Life Study of Prolonged Meropenem Infusion in Neonates and Children Admitted to Intensive Care Units: Are Three Hours Long Enough?

Early bone marrow alterations in patients with adenosine deaminase 2 deficiency across disease phenotypes and severities

Detection of plasma circulating GD2 ganglioside in patients with neuroblastoma and age-matched healthy children. Diagnostic and prognostic evaluation

Long-term plasma monitoring of THC and CBD in pediatric drug-resistant epilepsy: Implications for cannabidiol therapy with Epidyolex®

Validation of an LC-MS/MS method for urinary homovanillic and vanillylmandelic ACIDS and application to the diagnosis of neuroblastoma

Multidose Dalbavancin Population Pharmacokinetic Analysis for Prolonged Target Attainment in Patients Requiring Long-Term Treatment

Therapeutic Drug Monitoring of Elexacaftor, Tezacaftor, and Ivacaftor: An Overview of Bioanalytical Methods

Therapeutic drug monitoring of selumetinib in pediatrics: a combined LC-MS/MS and LC-HRMS approach

Dalbavancin Pharmacokinetics in an 18-Month-Old Child Undergoing Extracorporeal Membrane Oxygenation: A Short Communication

Il monitoraggio del delta-9-tetraidrocannabinolo plasmatico in età pediatrica

Collaborators (14)

Federica Pigliasco

Maurizio Miano

Domenico Mavilio

Arinna Bertoni

Carlo Castellani

Maria Valeria Corrias

Giacomo Brisca

carolina saffioti

Francesca Mattioli

Andrea Santangelo

Diego Gilioli

Silvia Della Bella

Antonello Di Paolo

Genny Del Zotto

Make your next move.